Testing effectiveness (Phase 2)Ended earlyNCT00086164
What this trial is testing
Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
Who this might be right for
HyperplasiaChronic Renal Failure
Anesiva, Inc.